[1]
Matteucci, E.; Giampietro, O. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr. Med. Chem., 2009, 16, 2943-2951.
[2]
MacDonald, P.E.; El-kholy, W.; Riedel, M.J.; Salapatek, A.M.F.; Light, P.E.; Wheeler, M.B. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes, 2002, 51, S434-S442.
[3]
Lambeir, A-M.; Durinx, C.; Scharpe, S.; Meester, I.D. Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci., 2003, 40, 209-294.
[4]
Fan, J.; Johnson, M.H.; Lila, M.A.; Yousef, G.; de Mejia, E.G. Berry and citrus phenolic compounds inhibit dipeptidyl peptidase IV: Implications in diabetes management. Evidence-Based Complementary In: Altern. Med.,; , 2013. 2013, Article ID 479505.
[5]
Pandey, N.; Tripathi, Y.B. Antioxidant activity of tuberosin isolated from Pueraria tuberosa Linn. J. Inflamm. (Lond.), 2010, 7, 47.
[6]
Pandey, N.; Yadav, D.; Pandey, V.; Tripathi, Y.B. Antiinflammatory effect of Pueraria tuberosa extracts through improvement in activity of red blood cell anti-oxidant enzymes. Ayu, 2013, 34, 297-301.
[7]
Tripathi, A.K.; Kohli, S. Anti-diabetic activity and phytochemical screening of crude extracts of Pueraria tuberosa DC. (Fabaceae) grown in india on STZ-induced diabetic rats. Asian J. Med. Pharm., 2013, 3, 66-73.
[8]
Maji, A.K.; Pandit, S.; Banerji, P.; Banerjee, D. Pueraria tuberosa: A review on its phytochemical and therapeutic potential. Nat. Prod. Res., 2014, 28, 2111-2127.
[9]
Srivastava, S.; Koley, T.K.; Singh, S.K.; Tripathi, Y.B. The tuber extract of Pueraria tuberosa linn. competitively inhibits DPP-IV activity in normoglycemic rats. Int. J. Pharm. Pharm. Sci., 2015, 7, 227-231.
[10]
Srivastava, S.; Shree, P.; Tripathi, Y.B. Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach. J. Diabetes Metab. Disord., 2017, 16, 46.
[11]
Umezawa, H.; Aoyagi, H.; Ogawa, K. Diprotein A and B, inhibitors of dipeptidyl amino peptidase IV, produced by bacteria. J. Antibiot. (Tokyo), 1984, 26, 422-425.
[12]
Yogisha, S.; Raveesha, K.A. Dipeptidyl peptidase IV inhibitory activity of Magnifera indica. J. Nat. Prod., 2010, 3, 76-79.
[13]
Upwar, N.; Patel, R.; Waseem, N.; Mahobia, N.K. Hypoglycemic effect of methanolic extract of Berberis aristata DC stem on normal and streptozotocin induced diabetic rats. Int. J. Pharm. Pharm. Sci., 2011, 3, 222-224.
[14]
Chakrabarti, R.; Bhavtaran, S.; Narendra, P.; Varghese, N.; Vanchhawng, L.; Shihabudeen, H. M.S.; Thirumurgan, K. Dipeptidyl peptidase-IV inhibitory activity of Berberis aristata. J. Nat. Prod., 2011, 4, 158-163.
[15]
Okyar, A.C.; Akev, A.; Baktir, N. N.; Sutlupinar, T. Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytother. Res., 2001, 15, 157-161.
[16]
Prasanna, R.C.; Venkataraman, K. Aloe vera phytochemicals inhibits dipeptidyl peptidase IV (DPP-IV), an anti-diabetic agent. Int. J. Pharma Bio Sci., 2016, 7, 120-128.
[17]
Bisht, R.; Bhattacharya, S.; Jaliwala, Y.A. Evaluating the use of Desmodium gangeticum as alpha Glucosidase and DPPIV inhibitor for type-II diabetes. Am. J. Phytomed. Clin. Ther., 2014, 2, 530-539.
[18]
Kirtikar, K.R.; Basu, B.D. Indian Medicinal Plants, 2nd ed Vol. I.; International Book Distributors: Dehradun, India, 1987.
[19]
Rathi, A.; Rao, C.V.; Ravishankar, B.; Deb, S.; Mehrotra, S. Anti-inflammatory and antinociceptive activity of the water decoction Desmodium gangeticum. J. Ethnopharmacol., 2004, 95, 259-263.
[20]
Bisht, R.; Bhattacharya, S. Effect of various extracts of Desmodium gangeticum on streptozotocin-nicotinamide induced type-2 diabetes. Asian J. Plant Sci. Res., 2013, 3, 28-34.
[21]
Bharti, S.K.; Krishnan, S.; Kumar, A.; Rajak, K.K.; Murari, K.; Bharti, B.K.; Gupta, A.K. Antihyperglycemic activity with DPP-IV inhibition of alkaloids from seed extract of Castanospermum australe: Investigation by experimental validation and molecular docking. Phytomedicine, 2012, 20, 24-31.
[22]
Atique, A.; Iqbal, M.; Ghouse, A.K.M. Use of Annona squamosa and Piper nigrum against diabetes. Fitoterapia, 1985, 56, 190-192.
[23]
Topno, K.K. Plants used by tribals of Chotanagpur against diabetes. Botanica, 1997, 47, 99-101.
[24]
Gupta, R.K.; Kesari, A.N.; Murthy, P.S.; Chandra, R.; Tandon, V.; Watal, G. Hypoglycemic and antidiabetic effect of ethanolic extract of leaves of Annona squamosa L. in experimental animals. J. Ethnopharmacol., 2005, 99, 75-81.
[25]
Kato, E.; Uenishi, Y.; Inagaki, Y.; Kurokawa, M.; Kawabata, J. Isolation of rugosin A, B and related compounds as dipeptidyl peptidase-IV inhibitors from rose bud extract powder. Biosci. Biotechnol. Biochem., 2016, 80(11), 2087-2092.
[26]
Kim, B.R.; Kim, H.Y.; Choi, I.; Kim, J.B.; Jin, C.H.; Han, A.R. DPP-IV inhibitory potentials of flavonol glycosides isolated from the seeds of Lens culinaris: In vitro and molecular docking analyses. Molecules, 2018, 23, 1998.
[27]
Nongonierma, A.B.; Le Maux, S.; Dubrulle, C.; Barre, C.; FitzGerald, R.J. Quinoa (Chenopodium quinoa Willd.) protein hydrolysates with in vitro dipeptidyl peptidase IV (DPP-IV) inhibitory and antioxidant properties. J. Cereal Sci., 2015, 65, 112-118.
[28]
Ekayanti, M.; Sauriasari, R.; Elya, B. Dipeptidyl peptidase IV inhibitory activity of fraction from white tea ethanolic extract (Camellia sinensis (L.) Kuntze) ex vivo. Pharmacogn. J., 2018, 10, 190-193.
[29]
Ahmad, M.; Khan, M.A.; Arshad, M.; Zafar, M. Ethnophytotherapical
approaches for the treatment of diabetes by the local
inhabitants of district Attock (Pakistan). Ethnobotanical Leaflet, 2004. 2004, Article 7.
[30]
Aneel Gilani, S.; Qureshi, R.A.; Javaria Gilani, S. Indigenous uses of some important ethnomedicinal herbs of Ayubia National Park, Abbottabad, Pakistan. Ethnobotanical Leaflet, 2006, 10, 285-293.
[31]
Saleem, S.; Jafri, L. ul Haq, I.; Chang, L.C.; Calderwood, D.; Green, B.D.; Mirza, B. Plants Fagonia cretica L. and Hedera nepalensis K. Koch contain natural compounds with potent dipeptidyl peptidase-4 (DPP-4) inhibitory activity. J. Ethnopharmacol., 2014, 156, 26-32.
[32]
Velarde-Salcedo, A.J.; Barrera-Pacheco, A.; Lara-Gonzalez, S.; Montero-Moran, G.M.; Diaz-Gois, A.; de Mejia, E.G.; Barba de la Rosa, A.P. In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins. Food Chem., 2013, 136, 758-764.
[33]
Dey, B.; Mitra, A.; Katakam, P.; Singla, R.K. Exploration of natural enzyme inhibitors with hypoglycemic potentials amongst Eucalyptus Spp. by in vitro assays. World J. Diabetes, 2014, 5, 209-218.
[34]
Borde, M.K.; Mohanty, I.R.; Maheshwari, U.; Suman, R.K.; Deshmukh, Y.A. Natural dipeptidyl peptidase-4 inhibitor Terminalia arjuna mitigates myocardial infarction co-existing with diabetes in experimental rats. J. Diabetes Metab. Disord. Control, 2018, 5, 48-56.
[35]
Matsabisa, M.G.; Chukwuma, C.I.; Chaudhary, S.K. South African traditional herbal formulation inhibits α-glucosidase, DPP-IV and glycation activities, and modulates glucose utilisation in Chang liver cells and 3T3-L1 adipocytes. S. Afr. J. Bot., 2019, 121, 121-127.
[36]
Gallego, M.; Aristoy, M.C.; Toldra, F. Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham. Meat Sci., 2014, 96, 757-761.
[37]
Li-Chan, E.C.Y.; Hunag, S.L.; Jao, C.L.; Ho, K.P.; Hsu, K.C. Peptides derived from Atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors. J. Agric. Food Chem., 2012, 60, 973-978.
[38]
Huang, N.L. Fuscoporia obliqua-a mysterious folk medicinal mushroom in Russia. Edible Fungi of China, 2002, 4, 7-8.
[39]
Sun, J.E.; Ao, Z.H.; Lu, Z.M.; Xu, H.Y.; Zhang, X.M.; Dou, W.F.; Xu, Z.H. Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice. J. Ethnopharmacol., 2008, 118, 7-13.
[40]
Geng, Y.; Lu, Z.M.; Huang, W.; Xu, H.Y.; Shi, J.S.; Xu, Z.H. Bioassay-guided isolation of DPP-4 inhibitory fractions from extracts of submerged cultured of Inonotus obliquus. Molecules, 2013, 18, 1150-1161.
[41]
Konrad, B.; Anna, D.; Marek, S.; Marta, P.; Aleksandra, Z.; Jozefa, C. The evaluation of dipeptidyl peptidase (DPP)-IV, α-glucosidase and angiotensin converting enzyme (ACE) inhibitory activities of whey proteins hydrolyzed with serine protease isolated from Asian pumpkin (Cucurbita ficifolia). Int. J. Pept. Res. Ther., 2014, 20, 483-491.
[42]
Lacroix, I.M.E.; Li-Chan, E.C.Y. Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach. J. Funct. Foods, 2012, 4, 403-422.
[43]
Lacroix, I.M.E.; Li-Chan, E.C.Y. Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. Int. Dairy J., 2012, 25, 97-102.
[44]
Naseri, R.; Farzaei, F.; Haratipour, P.; Nabavi, S.F.; Habtemariam, S.; Farzaei, M.H.; Khodarahmi, R.; Tewari, D.; Momtaz, S. Anthocyanins in the management of metabolic syndrome: A pharmacological and biopharmaceutical review. Front. Pharmacol., 2018, 9, 1310.
[45]
Rasouli, H.; Farzaei, M.H.; Khodarahmi, R. Polyphenols and their benefits: A review. Int. J. Food Prop., 2017, 20, 1700-1741.
[46]
Das, R.; Gogoi, D.; Bhoumick, S.; Saikia, S.; Bezbaruah, R.L.; Bora, T.C.; Sarma, K.; Sahu, M.; Barooah, M. 3D- comparative modelling, structure comparison & docking studies for AVPR2 protein with some anti-diabetic plant compounds from North East India. Indo Global J. Pharm. Sci., 2014, 4, 8-17.
[47]
Bhattacharjee, R.; Mitra, A.; Dey, B.; Pal, A. Exploration of anti-diabetic potentials amongst marine species- a mini review. Indo Global J. Pharm. Sci., 2014, 4, 65-73.
